Previous Article | Next Article 
Journal of Bacteriology, March 2001, p. 2025-2031, Vol. 183, No. 6
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.6.2025-2031.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of the varR Gene as a
Transcriptional Regulator of Virginiamycin S Resistance in
Streptomyces virginiae
Wises
Namwat,1
Chang-Kwon
Lee,1
Hiroshi
Kinoshita,1
Yasuhiro
Yamada,2 and
Takuya
Nihira1,*
Department of Biotechnology, Graduate School of
Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka
565-0871,1 and Department of Applied
Biological Science, Faculty of Engineering, Fukuyama University, 1 Gakuenmachi, Fukuyama, Hiroshima 729-0292,2
Japan
Received 25 August 2000/Accepted 20 December 2000
 |
ABSTRACT |
A gene designated varR (for virginiae
antibiotic resistance regulator) was identified in Streptomyces
virginiae 89 bp downstream of a varS gene encoding a
virginiamycin S (VS)-specific transporter. The deduced varR
product showed high homology to repressors of the TetR family with a
conserved helix-turn-helix DNA binding motif. Purified recombinant VarR
protein was present as a dimer in vitro and showed clear DNA binding
activity toward the varS promoter region. This binding was
abolished by the presence of VS, suggesting that VarR regulates
transcription of varS in a VS-dependent manner. Northern
blot analysis revealed that varR was cotranscribed with
upstream varS as a 2.4-kb transcript and that VS acted as
an inducer of bicistronic transcription. Deletion analysis of the
varS promoter region clarified two adjacent VarR binding
sites in the varS promoter.
 |
INTRODUCTION |
Streptomyces species are
gram-positive filamentous bacteria that are well-known for producing a
vast array of bioactive compounds, including more than 70% of the
commercially important antibiotics. The production of antibiotics by
these organisms is regulated by a variety of physiological and
nutritional conditions, often coordinated with processes of
morphological differentiation, such as formation of aerial mycelia and
spores. A detailed knowledge of the signal cascade and the genetic
components involved in antibiotic production will enable the
construction of strains that can overproduce these commercially
important compounds.
Previous studies have shown that antibiotic production and/or
morphological differentiation is controlled in some
Streptomyces species by low-molecular-weight compounds
called
-butyrolactone autoregulators (28, 34). Because
the
-butyrolactone autoregulators are effective at an extremely low
concentration and their signal is transmitted into cells by binding to
specific cytoplasmic receptor proteins, the autoregulators are regarded
as Streptomyces hormones. To date, 10
-butyrolactone
autoregulators have been isolated and have had their structures
chemically identified (33). Among the
-butyrolactone
autoregulators and receptor proteins identified so far,
virginiae butanolides (VBs) of Streptomyces
virginiae (18, 26, 32) and the VB receptor protein
(BarA) (16, 23) are two of the most frequently studied,
and the VB-BarA system has been confirmed to regulate the coordinate
production of two structurally different compounds, virginiamycin
M1 (VM1) and virginiamycin S (VS), a pair of
antibiotics that show strong synergistic bactericidal activity
(22).
Previous in vitro (16) and in vivo analyses (16,
22) have demonstrated that the VB receptor BarA is a DNA binding
transcriptional repressor. In the absence of VB, BarA binds to the
specific DNA sequences in the promoter region of a target gene(s)
and/or operon(s), which represses the transcription. When VB is
produced, binding of VB to DNA-bound BarA results in the dissociation
of BarA from the promoter region, which initiates the transcription of
the target gene and/or operon. In our previous study, a target operon designated barB-varS was located immediately downstream of
the barA gene, and the varS gene was shown to
encode a VS-specific efflux protein taking part in virginiamycin
resistance (20). In the course of this earlier study, it
was noticed that varS was also transcribed with the
downstream region, and the transcript was increased by the presence of
VS, suggesting the presence of complex regulation on virginiamycin resistance.
In this study, to clarify the overall regulation mechanism governing
virginiamycin resistance, the varS downstream region was
sequenced and an open reading frame (ORF) (varR) encoding a
TetR-type repressor was identified. A transcriptional analysis of
varR, as well as an in vitro gel-shift analysis using the
recombinant VarR protein, demonstrated that VarR is a DNA binding
regulator which mediates the VS-dependent transcription of the
varS gene.
 |
MATERIALS AND METHODS |
Strains, growth conditions, and plasmids.
S.
virginiae (strain MAFF 10-06014; National Food Research Institute,
Ministry of Agriculture, Forestry, and Fisheries, Tsukuba, Japan) was
grown at 28°C as described previously (15, 32). pUC18
and pUC19 were used for genetic manipulation in Escherichia coli, and pUC19 was used for DNA sequencing. For the genetic
manipulation in E. coli, strain DH5
(10)
was used. DNA manipulations in E. coli were performed as
described by Sambrook et al. (27).
Chemicals.
All chemicals were of reagent or high-performance
liquid chromatography (HPLC) grade and were purchased from either
Nacalai Tesque (Osaka, Japan), Takara Shuzo (Shiga, Japan), or Wako
Pure Chemical Industries, Ltd. (Osaka, Japan). The RNA ladder was
obtained from GIBCO BRL (Gaithersburg, Md.).
[
-32P]dCTP was purchased from ICN Biomedicals Inc.
(Costa Mesa, Calif.). VM1 and VS were purified by a
previously described method (19).
DNA sequencing and sequence analysis.
The nucleotide
sequence was determined for both strands using an ALF red DNA sequencer
(Amersham Pharmacia Biotech, Tokyo, Japan). Sequencing reactions were
carried out with a Thermo sequencing kit (Amersham Pharmacia Biotech)
according to the manufacturer's instructions. Homology searches were
carried out using the programs BLAST (1) and FASTA
(25).
RNA preparation and Northern blot analysis.
Total RNA was
isolated by the method of Kirby et al. (17), with
modifications by Hopwood et al. (13), and was quantified by absorbance at 260 nm. RNA (10 µg) was loaded on each lane, electrophoresed on a 1.2% agarose gel, and transferred to Hybond-N+ (Amersham Pharmacia Biotech) according to the manufacturer's
recommendations. Hybridization was carried out at 65°C for 1 h
in Rapid-hyb buffer (Amersham Pharmacia Biotech) followed by washing of
the blot three times at 50°C for 10 min with 2× SSC (1× SSC
contains 0.015 M sodium citrate and 0.15 M NaCl [pH 7.7]) containing
0.1% sodium dodecyl sulfate (SDS). The NotI-SphI
and StuI-BamHI fragments were used as specific
probes against varR and barB, respectively (Fig.
1). The DNA fragments were labeled with
[
-32P]dCTP by using the random primer DNA labeling kit
(version 2) (Takara Shuzo Co.).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Gene organization in the 6.8-kb
BamHI-PstI region containing varS in
S. virginiae. Probes used for the Northern blot analysis of
barB (StuI-BamHI fragment) and
varR (NotI-SphI fragment) are
indicated by solid boxes. Intergenic regions between barB
and varS (Eco52I-BsaI fragment;
SVK14.2 in Fig. 5A) and between varS and varR
(NaeI-BssHII fragment; SVK13.1 in Fig. 5A) used
for the gel-shift assay are indicated by shaded boxes. These fragments
were cloned in pUC19 and were FITC labeled as described in Materials
and Methods.
|
|
Overexpression of varR and purification of
recombinant VarR protein (rVarR).
varR was amplified by
PCR using oligonucleotides
5'-ATACATATGTGGCCGCCAAGCGCGC-3' and
5'-TATGGATCCCAGTCACACATGCCGGC-3' containing artificial NdeI and BamHI recognition sites,
respectively. The amplified product was digested with NdeI
and BamHI and was ligated into
NdeI-BamHI-digested pET32a(+) (Novagen, Madison,
Wis.), resulting in six surplus His codons at the 3' end of
varR. This plasmid (pVN303) was introduced into E. coli BL21(DE3)/pLysS, and the transformed cells were cultured in
Luria broth containing ampicillin (25 µg/ml) and chloramphenicol (25 µg/ml). When growth reached an absorbance of 0.6 at 600 nm,
isopropyl-
-D-thiogalactopyranoside (IPTG) (final
concentration of 1 mM) was added to the culture, followed by a further
2 h of cultivation. Cells were harvested by centrifugation at
7,000 × g for 15 min at 4°C, washed with 0.05 M
triethanolamine-HCl (pH 7), and resuspended in buffer A [0.05 M
triethanolamine-HCl (pH 7) containing 0.2 M KCl, 20% (vol/vol) glycerol, 5 mM dithiothreitol (DTT), and 0.5 mM
p-amidinophenylmethanesulfonyl fluoride]. The cells
were disrupted by sonication for 2 min at 25% duty cycle (Branson
Sonifier 250) in an ice bath, followed by centrifugation at
10,000 × g for 15 min at 4°C to obtain a supernatant
as crude lysate.
The crude lysate was applied to a DEAE-Sephacel column, and the
adsorbed proteins were eluted with a linear gradient of KCl
concentrations from 0.1 to 0.5 M in 50 mM triethanolamine-HCl
containing 20% (vol/vol) glycerol (pH 7). Fractions containing
rVarR
were mixed and loaded on a Ni-NTA column (Qiagen, Tokyo,
Japan).
Unbound proteins were washed out with buffer A (minus
DTT) containing
0.1 mM imidazole, and rVarR was eluted with buffer
A (minus DTT)
containing 10 mM
imidazole.
Preparation of crude lysate from S. virginiae.
The S. virginiae culture was initiated by inoculating 2.1 ml
of preculture into 70 ml of f medium (15) in a 500-ml
baffled flask. After cultivation at 28°C for 14 h on a
reciprocating shaker (120 strokes per min), cells were harvested by
centrifugation (3,000 × g, 10 min, 4°C). The cells
were suspended in buffer A and were disrupted by sonication as
described above. After centrifugation, the supernatant was stored at
20°C and was used as the source of native VarR of S. virginiae.
Gel-shift assay.
The binding mixture consisted of a protein
sample (100 µg of crude lysate or 20 µg of purified rVarR) and 0.5 nM fluorescein isothiocyanate (FITC)-labeled fragment in 1× binding
buffer [50 mM triethanolamine-HCl (pH 7.0) containing 0.2 M KCl, 10%
(vol/vol) glycerol, and 1.5 µg of poly(dI-dC) · poly(dI-dC)]
in a total volume of 20 µl. After incubation at 25°C for 10 min,
the reaction mixture was separated at 4°C by electrophoresis on a
high-ionic-strength gel containing 5% acrylamide and 0.167% N,
N'-methylenebisacrylamide with a running buffer of 50 mM Tris-HCl
(pH 8.5) containing 380 mM glycine and 2 mM EDTA. The DNA fragments in
the gel were detected by a fluorometry scanner (FMBIO; Hitachi). The
FITC labeling was performed by PCR on fragments subcloned in pUC19 as
templates, using an FITC-labeled forward primer (5'
FITC-CGCCAGGGTTTTCCCAGTCACGAC-3') and a reverse primer (5'
FITC-TTTCACACAGGAAACAGCTATGAC-3').
Nucleotide sequence accession number.
The nucleotide
sequence data reported in this paper has been submitted to the
DDBJ/EMBL/GenBank data bank as accession number AB046994.
 |
RESULTS AND DISCUSSION |
Sequence of the varS downstream region and
identification of the varR gene.
To search for
regulatory genes responsible for the VS-dependent increase in the
varS transcript, the 0.9-kb region downstream of
varS was sequenced. FRAME analysis (3) of the
region identified a 744-bp ORF starting 89 bp downstream of the
varS stop codon in the same direction as varS
(Fig. 1). The ORF product (247 amino acids,
Mr = 27,296) showed significant homology
with Amycolatopsis mediterranei RifQ (63% identity, 78%
similarity), a transcriptional repressor for the rifamycin efflux
protein RifP (2). Moderate homology of 33 to 38% identity
was also observed with several transcriptional repressors, such as a
class D tetracycline repressor of E. coli (TetR) or a TetR
homolog of Streptomyces coelicolor. Multiple alignment of
the deduced ORF product with the member repressors of the TetR family
revealed that the most significant identity exists at an amino-terminal
region containing a helix-turn-helix DNA binding motif (Fig.
2). The presence of the helix-turn-helix structure was also supported by the high score (SD score of 5.18) for
the prediction of the motif (7). Thus, the ORF can be
assumed to encode a DNA binding regulator and was designated
varR (for virginiae antibiotic resistance
regulator) due to its regulatory function on varS
transcription (described in detail below).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
Multiple alignment of VarR and several repressors of the
TetR family, including a repressor of rifamycin resistance from
A. mediterranei (RifQ) (2, 14), a TetR homolog
from S. coelicolor (8), a transcriptional
regulator of Deinococcus radiodurans (Deinococcus)
(31), a class D tetracycline repressor of E. coli (TetR class D) (30), TetR of Salmonella
enterica serovar Typhimurium DT104 (Salmonella) (5),
and TetR of Pseudomonas sp. (Pseudomonas) (29).
Identical residues are indicated by white letters in black boxes.
|
|
Transcriptional analysis of the varR gene.
To
deduce the in vivo function of varR, the time course of the
transcription was investigated by Northern blot analysis using the
varR-coding region as a probe against RNA samples from 8- to
16-h cultures of S. virginiae (Fig.
3A). Although the signals were faint,
varR transcript was detected as a 2.4-kb band in the 10- and
12-h samples, and the signal intensity reached a maximum at 14 h
of cultivation, which agreed well with the onset of virginiamycin production in S. virginiae (16). Because the
size of the transcript (2.4 kb) was far larger than that of
varR alone (0.7 kb), and because the upstream
varS-specific probe hybridized to the same band
(20) while the probe covering the downstream region did not (data not shown), we concluded that varR formed an
operon with the upstream varS gene. This conclusion agreed
well with the lack of typical promoter sequences in the 5' untranslated region of varR and the presence of an inverted repeat in the
3' region of varR (
G =
9.1 kcal) as a
plausible transcriptional terminator.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot hybridization analysis of varR
transcription. (A) varR transcription during cultivation of
S. virginiae. Total RNA was extracted from cells cultivated
for the indicated period at 28°C. Under the experimental conditions,
the production of VB and virginiamycin started at 10 and 14 h of
cultivation, respectively, as shown by arrows above the lanes. (B) The
effect of virginiamycin addition on the transcription of
varR. VM1 (10 µg/ml) or VS (10 µg/ml) was
added to the culture at 8 h of cultivation. The term noninduced
indicates that virginiamycin was not added. (C and D) Effect of VB
addition on the transcription of barB (C) and
varR (D). RNA was prepared from cells with VB
(VB-C6, 300 nM) added at 8 h of cultivation. A
varR-specific probe (NotI-SphI
fragment, shown in Fig. 1) was used in panels A, B, and D to detect the
2.4-kb varS-varR transcript, and a
barB-specific probe (StuI-BamHI
fragment, shown in Fig. 1) was used in panel C to detect the 2.5-kb
barB-varS transcript.
|
|
Our previous analysis of the
barB-varS operon
(
20) and the present data on the
varS-varR
operon indicated that the
varS gene is transcribed in three
different ways: as a monocistronic
transcript (1.6 kb)
(
20), as a bicistronic
barB-varS transcript
(2.5 kb) (
20), and as a bicistronic
varS-varR
transcript (2.4
kb). The presence of a perfectly matched inverted
repeat sequence
10 bp downstream of the
varS stop codon
seems to dictate that
the transcriptional termination is after
varS. Although the
barB-varS transcript and the
varS-varR transcript are very similar in size,
they can be
easily distinguished by use of specific probes, such
as those internal
to
barB and
varR. Just as in a previous study,
where the use of the
varS-specific probe confirmed that the
2.4-kb
bicistronic transcription was induced by the presence of VS
(
20),
in the present study the
varR-specific
probe confirmed that the
transcription of the
varS-varR
operon was induced by the addition
of VS at 8 h of cultivation but
not by VM
1 (a synergistic counterpart
of VS in the
virginiamycin mixture) (Fig.
3B).
The effect of VB on the transcription of the
varS-varR
operon was also investigated by adding VB at 8 h of cultivation
(Fig.
3C and D). Just as in our previous study (
20), we
observed a
large increase of the 2.5-kb
barB-varS
bicistronic transcript
1 h after the VB addition (Fig.
3C), which
is the typical induction
pattern under the direct control of the
VB-BarA system. The 0.8-kb
band seemed to be the degradation product
from the 2.5-kb transcript
by posttranscriptional processing. With
regard to the 2.4-kb
varS-varR bicistronic transcript,
however, induction was observed only 2
h after the VB addition (10 h of cultivation) (Fig.
3D), which
suggests that the VB-BarA system
does not directly control the
varS-varR transcription.
Overproduction and purification of rVarR.
To evaluate the
actual function of VarR, we overexpressed rVarR in E. coli.
rVarR with six surplus histidine residues at the C terminus was
purified with successive chromatographies on a DEAE-Sephacel and a
Ni-NTA column, and the purity was confirmed by SDS-polyacrylamide gel
electrophoresis (Fig. 4A). A protein of
27 kDa was observed in the extracts of IPTG-induced cells carrying the
varR gene in pET32a(+) (pVN303; see Materials and Methods for its construction), whereas the corresponding band was absent in the
extracts of cells carrying vector pET32a(+). The molecular mass of 27 kDa agreed well with that calculated from the nucleotide sequence
(Mr = 27,296), and N-terminal amino
sequencing of the purified sample confirmed that the 27-kDa protein is
rVarR (data not shown). The native molecular size of the purified rVarR
was determined to be 67 kDa by molecular-sieve HPLC on a TSK gel
G3000SWXL (TOSO) column (Fig. 4B). Therefore, we concluded
that rVarR existed as a dimer consisting of two 27-kDa subunits,
similar to the cases of other member repressors of the TetR family
(5, 12, 29, 30).

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Overexpression and purification of rVarR. A sample
from each purification step was separated on an SDS-10%
polyacrylamide gel and was stained with Coomassie brilliant blue R-250
(27). Lane 1, molecular mass protein standard; lane 2, crude lysate (10 µg) of E. coli BL21(DE3)/pLysS containing
pET32a as a negative control; lane 3, crude lysate (10 µg) of
E. coli BL21(DE3)/pLysS containing pVN303; lane 4, eluate (7 µg) from DEAE-Sephacel chromatography; lane 5, eluate (7 µg) from
Ni-NTA affinity chromatography. The arrow indicates the position of
rVarR. (B) The elution profile of the purified rVarR from the
molecular-sieve HPLC on a TSK gel G3000SWXL (TOSO) column.
MW indicates the elution profiles of the standard proteins having the
molecular masses shown above the figure. OD280, optical
density at 280 nm.
|
|
In vitro functional analysis of VarR.
To clarify the function
of VarR, the DNA binding ability of both the purified rVarR and the
natural VarR of S. virginiae was assessed by gel-shift assay
(Fig. 5) against an FITC-labeled
Eco52I-BsaI fragment (SVK14.2) (Fig. 1). This
fragment covers the intergenic region between barB and
varS and corresponds to nucleotides (nt)
163 to +23
relative to the transcription start site of varS. rVarR
showed a clear band shift (Fig. 5A, lane 3), and the specific nature of
the binding was confirmed by competition with the unlabeled fragment
(Fig. 5A, lane 4). An identical specific binding was observed when
crude lysate of S. virginiae was used as a source of native
VarR (Fig. 5A, lane 7), thereby confirming that the C-terminal six
surplus His residues are not detrimental to the function of rVarR. When
the FITC-labeled NaeI-BssHII fragment (SVK13.1)
covering the varS-varR intergenic region was used, no band
shift was observed (Fig. 5A, lane 10). These results indicated that
rVarR specifically binds to the 5' upstream region of varS, not to the 5' upstream region of varR. This result seems to
corroborate the bicistronic nature of the varS-varR operon.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 5.
Gel-shift analyses on the DNA binding activity of VarR.
(A) DNA binding activity of purified rVarR to the FITC-labeled SVK14.2
(lanes 2 through 5), to SVK13.1 (lanes 9 and 10), and to the coding
region of the gene rplk (24), which encodes the
50S ribosomal protein L11, as a negative control (lanes 11 and 12, designated negative). See Fig. 1 for the regions covered by SVK14.2 and
SVK13.1. A nonlabeled barB-varS intergenic fragment (0.5 nM)
was added in lane 4 as competitor DNA. Lanes 5 and 8 contained 0.5 mM
VS. The activity of native VarR in the crude lysate from S. virginiae (VarR) to SVK14.2 was tested in lanes 6, 7, and 8. The
crude protein from S. virginiae was obtained from a 14-h
culture, at which time the transcription of varR reached a
maximum (Fig. 3A). FITC-labeled probe was omitted in lanes 1 and 6. The
lowest band and the top band in lanes 6, 7, and 8 are nonspecific
fluorescence bands due to unknown contaminants in the crude lysate. (B)
The effect of several antibiotics on the DNA binding activity of rVarR.
VS was added at a concentration of 0.5 mM. Antibiotics other than VS
were added at a concentration of 50 mM.
|
|
When VS was present in the reaction mixture of the gel-shift assay, the
binding of VarR to the
varS upstream region was clearly
inhibited (Fig.
5A, lanes 5 and 8, and B, lane 3). This inhibition
was
specific by VS, as evident from the lack of signs of inhibition
by the
other antibiotics tested (two peptidic antibiotics [valinomycin
and
gramicidin S] and three polyunsaturated macrolactone antibiotics
[VM
1, erythromycin, and avermectin B
1]), even
at a concentration
100 times higher than that of VS (Fig.
5B). From
these results,
it can be proposed that VarR plays a central role in the
VS-dependent
induction of the
varS-varR operon. VarR seems
to repress the transcription
of the
varS-varR operon by
binding to the
varS promoter region
until the onset of VS
production. When VS production starts, the
repression is relieved
through the dissociation of VarR from the
promoter region of
varS.
To localize more precisely the VarR binding region, a gel-shift assay
was conducted with various shorter fragments from the
barB-varS intergenic region (Fig.
6A). Gel-shift assays against
SVK14.3 and
SVK14.4 revealed that VarR bound to the right half
of the region
corresponding to nt

60 to +23 relative to the transcriptional
start
site of
varS (Fig.
6B). Because the target sequence of a
DNA
binding protein often shows a dyad symmetry reflecting the
symmetrical
structure of the dimeric protein (
21), dyad sequences
were
surveyed in SVK14.4, and two sequences (nt

39 to

20 and

19 to +2)
were found to be plausible VarR binding sites (Fig.
6C). The region
SVK14.5 containing the two dyad sequences (nt

39 to +2) showed clear
binding with VarR, whereas the rest of
SVK14.2 (SVK14.8 for nt +1 to
+23 and SVK14.9 for nt

163 to

40)
did not, indicating that the VarR
binding sites should be in the
region of nt

39 to +2 (Fig.
6B).
Because the VarR binding sites
overlapped with the predicted binding
sites for RNA polymerase
(both the nt

35 and

10 elements), it seems
likely that the transcription
of
varS is repressed when VarR
remains bound at these sites.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 6.
Determination of VarR binding sites. (A) Fragment map of
the barB-varS intergenic region used for the gel-shift
assay. The Eco52I-BsaI fragment was designated
SVK14.2. The fragment for nt 39 to +2 (SVK14.5) was PCR-amplified by
primers 5'-TCGGAATTCTCACTTGTACATCGTAT-3' and
5'-TTAGCATGCACTGTTCTACAACGTAT-3'. The fragment
for nt 163 to 19 (SVK14.6) was amplified by primers
5'-ATAGAATTCACGTCCGGCGCGCGCC-3' and
5'-GCCGCATGCGAGTTATACGATGTACAAG-3', and the
fragment for nt 19 to +23 (SVK14.7) was amplified by primers
5'-CGCGAATTCCTCATATACGTTGTAGAAC-3' and
5'-TATGCATGCGAGACCTCCCAGGAGTG-3'. The fragment
for nt 163 to 40 (SVK14.8) was amplified by primers
5'-ATAGAATTCACGTCCGGCGCGCGCC-3' and
5'-ATACTGCAGACATGCGGGTGAAGCCTG-3', and the
fragment for nt +3 to +23 (SVK14.9) was amplified by primers
5'-GCGGAATTCTTCCTCACTCACTCCTGG-3' and
5'-TATGCATGCGAGACCTCCCAGGAGTG-3'. All fragments
were cloned into SphI-EcoRI sites of pUC19 and
then were PCR-amplified with FITC-labeled primers as described in
Materials and Methods. (B) Binding of purified rVarR to the fragments.
FITC-labeled fragments used for the gel-shift assay are shown above the
lanes. (C) Promoter sequence of varS containing two dyad
symmetry sequences. The residues showing dyad symmetry are indicated by
white letters in black boxes or by double underlining. The open
triangles indicate the axis of symmetry for each dyad symmetry
sequence.
|
|
The two dyad sequences shared 12 consensus nucleotides
(5'-N
CN
TN
TACN
TNG
TAN
AACN-3'
[boldface indicates con-sensus nucleotide]) (Fig.
6C), but together
they can form a large dyad structure, with C at nt

19 as a center
of symmetry. To assess whether or not one of the two
dyad sequences
was sufficient for VarR binding, each of the two dyad
sequences
was tested for VarR binding (SVK14.6 for nt

163 to

20 and
SVK14.7
for nt

19 to +23). Both fragments showed clear retardation by
VarR, indicating that there are two adjacent VarR binding sites
on the
varS promoter. It should be noted that the shift level
observed for SVK14.7 was much smaller than that observed for SVK14.5,
although these fragments are similar in size. Such a difference
in
shift level was also observed between SVK14.6 and SVK14.2.
These
results suggested that fragments containing the two dyad
sequences
(SVK14.2 and SVK14.5) are bound with a greater number
of VarR molecules
than fragments containing only one dyad sequence
(SVK14.6 and SVK14.7),
resulting in greater
retardation.
Combining the data presented here with that from previous studies
(
16,
20), a plausible model for the transcriptional
regulation of the
varS-varR operon can be deduced as follows
(Fig.
7). Before the onset of VB
production

and hence before VS production

transcription
of
varS-varR is likely to be repressed by a small but
sufficient
amount of VarR derived from basal level transcription of
varR.
Alternatively, vegetative sigma factor might not work
for transcription
from the
varS promoter. When VB production
starts, VB-bound BarA
dissociates from the
barB promoter and
hence induces bicistronic
barB-varS transcription, which
confers VS resistance before the
onset of virginiamycin production. The
weak
varS-varR transcript
detected in this cultivation
period (from 10 to 12 h in Fig.
3A)
seems to reflect the
read-through of RNA polymerase from the
barB-varS region
into the
varS-varR region. When the production of
virginiamycin
starts, the binding of VS to VarR causes VarR to
dissociate from
the
varS promoter region, thereby leading to
derepression of
varS-varR transcription.
 |
ACKNOWLEDGMENT |
This study was supported in part by a grant from the Research for
the Future Program of the Japan Society for the Promotion of Science (JSPS).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan. Phone: 81-6-6879-7433. Fax:
81-6-6879-7432. E-mail:
nihira{at}biochem.bio.eng.osaka-u.ac.jp.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
August, P. R.,
L. Tang,
Y. J. Yoon,
S. Ning,
R. Muller,
T. W. Yu,
M. Taylor,
D. Hoffann,
C. G. Kim,
X. Zhang,
C. R. Hutchinson, and H. G. Floss.
1998.
Biosynthesis of ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699.
Chem. Biol.
5:69-78[CrossRef][Medline].
|
| 3.
|
Bibb, M. J.,
P. R. Findlay, and M. W. Johnson.
1984.
The relationship between base composition and codon usage in bacterial genes and its use for the simple and reliable identification of protein-coding sequences.
Gene
30:157-166[CrossRef][Medline].
|
| 4.
|
Bourn, W. R., and B. Babb.
1995.
Computer assisted identification and classification of Streptomycete promoters.
Nucleic Acids Res.
23:3696-3703[Abstract/Free Full Text].
|
| 5.
|
Briggs, C. E., and P. M. Fratamico.
1999.
Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104.
Antimicrob. Agents Chemother.
43:846-849[Abstract/Free Full Text].
|
| 6.
|
Caballero, J. L.,
F. Malpartida, and D. A. Hopwood.
1991.
Transcriptional organization and regulation of an antibiotic export complex in the producing Streptomyces culture.
Mol. Gen. Genet.
228:372-380[Medline].
|
| 7.
|
Dodd, I. B., and J. B. Egan.
1990.
Improve detection of helix-turn-helix DNA-binding motif in protein sequences.
Nucleic Acids Res.
18:5019-5026[Abstract/Free Full Text].
|
| 8.
|
Fernandez-Moreno, M. A.,
J. L. Caballero,
D. A. Hopwood, and F. Malpartida.
1991.
The act cluster contains regulatory and antibiotic export genes, direct targets for translation control by the bldA tRNA gene of Streptomyces coelicolor.
Cell
66:769-780[CrossRef][Medline].
|
| 9.
|
Guilfoile, P. G., and C. R. Hutchinson.
1992.
The Streptomyces glaucescens TcmR protein represses transcription of the divergently oriented tcmR and tcmA genes by binding to an intergenic operator region.
J. Bacteriol.
174:3659-3666[Abstract/Free Full Text].
|
| 10.
|
Hanahan, D.
1983.
Studies on transformation of Escherichia coli with plasmids.
J. Mol. Biol.
166:557-580[Medline].
|
| 11.
|
Hillen, W., and C. Berens.
1994.
Mechanisms underlying expression of TN10 encoded tetracycline resistance.
Annu. Rev. Microbiol.
48:345-369[Medline].
|
| 12.
|
Hinrichs, W.,
C. Kisker,
M. Duvel,
A. Muller,
K. Tover,
W. Hillen, and W. Saenger.
1994.
Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance.
Science
264:418-420[Abstract/Free Full Text].
|
| 13.
|
Hopwood, D. A.,
M. J. Bibb,
K. F. Chater,
C. J. Bruton,
H. M. Kieser,
D. J. Lydiate,
C. P. Smith,
J. M. Ward, and H. Schrempf.
1985.
Genetic manipulation of Streptomyces: a laboratory manual.
The John Innes Foundation, Norwich, United Kingdom.
|
| 14.
|
Kim, C. G.,
T. W. Yu,
C. Fryhle,
S. Handa, and H. G. Floss.
1998.
3-Amino-5-hydroxybenzoic acid synthase, the terminal enzyme in the formation of the precursor of mC7N units in rifamycin and related antibiotics.
J. Biol. Chem.
273:6030-6040[Abstract/Free Full Text].
|
| 15.
|
Kim, H. S.,
T. Nihira,
H. Tada,
M. Yanagimoto, and Y. Yamada.
1989.
Identification of binding protein of virginiae butanolide C, an autoregulator in virginiamycin production, from Streptomyces virginiae.
J. Antibiot.
42:769-778[Medline].
|
| 16.
|
Kinosita, H.,
H. Ipposhi,
S. Okamoto,
H. Nakano,
T. Nihira, and Y. Yamada.
1997.
Butyrolactone autoregulator receptor protein (BarA) as a transcriptional regulator in Streptomyces virginiae.
J. Bacteriol.
179:6986-6993[Abstract/Free Full Text].
|
| 17.
|
Kirby, T.,
E. Fox-Carter, and M. Guest.
1967.
Isolation of deoxyribonucleic acid and ribosomal ribonucleic acid from bacteria.
Biochem. J.
104:258-262[Medline].
|
| 18.
|
Kondo, K.,
Y. Higuchi,
S. Sakuda,
T. Nihira, and Y. Yamada.
1989.
New virginiae butanolides from Streptomyces virginiae.
J. Antibiot.
42:1873-1876[Medline].
|
| 19.
|
Lee, C. K.,
M. Minami,
S. Sakuda,
T. Nihira, and Y. Yamada.
1996.
Stereospecific reduction of virginiamycin M1 as the virginiamycin resistance pathway in Streptomyces virginiae.
Antimicrob. Agents Chemother.
40:595-601[Abstract].
|
| 20.
|
Lee, C. K.,
Y. Kamitani,
T. Nihira, and Y. Yamada.
1998.
Identification and in vivo functional analysis of virginiamycin S resistance gene (varS) from Streptomyces virginiae.
J. Bacteriol.
181:3293-3297[Abstract/Free Full Text].
|
| 21.
|
Lewin, B.
1997.
Genes VI, p. 348-353.
Oxford University Press, New York, N.Y.
|
| 22.
|
Nakano, H.,
E. Takehara,
T. Nihira, and Y. Yamada.
1998.
Gene replacement analysis of the Streptomyces virginiae barA gene encoding the butyrolactone autoregulator receptor reveals that BarA acts as a repressor in virginiamycin biosynthesis.
J. Bacteriol.
180:3317-3322[Abstract/Free Full Text].
|
| 23.
|
Okamoto, S.,
K. Nakajima,
T. Nihira, and Y. Yamada.
1995.
Virginiae butanolide binding protein from Streptomyces virginiae.
J. Biol. Chem.
270:12319-12326[Abstract/Free Full Text].
|
| 24.
|
Okamoto, S.,
T. Nihira,
H. Kataoka,
A. Suzuki, and Y. Yamada.
1992.
Purification and molecular cloning of a butyrolactone autoregulator receptor from Streptomyces virginiae.
J. Biol. Chem.
267:1093-1098[Abstract/Free Full Text].
|
| 25.
|
Pearson, W. R., and D. J. Lipman.
1988.
Imported tools for biological sequence comparison.
Proc. Natl. Acad. Sci. USA
85:2444-2446[Abstract/Free Full Text].
|
| 26.
|
Sakuda, S., and Y. Yamada.
1991.
Stereochemistry of butyrolactone autoregulators from Streptomyces.
Tetrahedron Lett.
32:1817-1820[CrossRef].
|
| 27.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 28.
|
Sato, K.,
T. Nihira,
S. Sakuda,
M. Yanagimoto, and Y. Yamada.
1989.
Isolation and structure of a new butyrolactone autoregulator from Streptomyces sp. FRI-5.
J. Ferment. Bioeng.
68:170-173[CrossRef].
|
| 29.
|
Schnabel, E. L., and A. L. Jones.
1999.
Distribution of tetracycline resistance genes and transposons among phylloplane bacteria in Michigan apple orchards.
Appl. Environ. Microbiol.
65:4898-4907[Abstract/Free Full Text].
|
| 30.
|
Tovar, K.,
A. Ernst, and W. Hillen.
1988.
Identification and nucleotide sequence of the class E tet regulatory elements and operator and inducer binding of the encoded purified Tet repressor.
Mol. Gen. Genet.
215:76-80[CrossRef][Medline].
|
| 31.
|
White, O.,
J. A. Eisen,
J. F. Heidelberg,
E. K. Hickey,
J. D. Peterson,
R. J. Dodson,
D. H. Haft,
M. L. Gwinn,
W. C. Nelson,
D. L. Richardson,
K. S. Moffat,
H. Qin,
L. Jiang,
W. Pamphile,
M. Crosby,
M. Shen,
J. J. Vamathevan,
P. Lam,
L. McDonald,
T. Utterback,
C. Zalewski,
K. S. Makarova,
L. Aravind,
M. J. Daly,
K. W. Minton,
R. D. Fleischmann,
K. A. Ketchum,
K. E. Nelson,
S. Salzberg,
H. O. Smith,
J. C. Venter, and C. M. Fraser.
1999.
Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1.
Science
286:1571-1577[Abstract/Free Full Text].
|
| 32.
|
Yamada, Y.,
K. Sugamura,
K. Kondo,
M. Yanagimoto, and H. Okada.
1987.
The structure of inducing factors for virginiamycin production in Streptomyces virginiae.
J. Antibiot.
40:496-504[Medline].
|
| 33.
|
Yamada, Y.,
T. Nihira, and S. Sakuda.
1997.
Butyrolactone autoregulators, inducers of virginiamycin in Streptomyces virginiae: their structures, biosynthesis, receptor proteins, and induction of virginiamycin biosynthesis, p. 63-79.
In
W. R. Strolhl (ed.), Biotechnology of antibiotics. Marcel Dekker, Inc, New York, N.Y.
|
| 34.
|
Yanagimoto, Y. K., and T. Enatsu.
1983.
Regulation of blue pigment production by g-nanolactone in Streptomyces sp.
J. Ferment. Technol.
61:545-550.
|
Journal of Bacteriology, March 2001, p. 2025-2031, Vol. 183, No. 6
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.6.2025-2031.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pulsawat, N., Kitani, S., Fukushima, E., Nihira, T.
(2009). Hierarchical control of virginiamycin production in Streptomyces virginiae by three pathway-specific regulators: VmsS, VmsT and VmsR. Microbiology
155: 1250-1259
[Abstract]
[Full Text]
-
Cerda-Maira, F. A., Ringelberg, C. S., Taylor, R. K.
(2008). The Bile Response Repressor BreR Regulates Expression of the Vibrio cholerae breAB Efflux System Operon. J. Bacteriol.
190: 7441-7452
[Abstract]
[Full Text]
-
Ramos, J. L., Martinez-Bueno, M., Molina-Henares, A. J., Teran, W., Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., Tobes, R.
(2005). The TetR Family of Transcriptional Repressors. Microbiol. Mol. Biol. Rev.
69: 326-356
[Abstract]
[Full Text]
-
Budarina, Z. I., Nikitin, D. V., Zenkin, N., Zakharova, M., Semenova, E., Shlyapnikov, M. G., Rodikova, E. A., Masyukova, S., Ogarkov, O., Baida, G. E., Solonin, A. S., Severinov, K.
(2004). A new Bacillus cereus DNA-binding protein, HlyIIR, negatively regulates expression of B. cereus haemolysin II. Microbiology
150: 3691-3701
[Abstract]
[Full Text]
-
Grkovic, S., Brown, M. H., Skurray, R. A.
(2002). Regulation of Bacterial Drug Export Systems. Microbiol. Mol. Biol. Rev.
66: 671-701
[Abstract]
[Full Text]
-
Santangelo, M. P., Goldstein, J., Alito, A., Gioffre, A., Caimi, K., Zabal, O., Zumarraga, M., Romano, M. I., Cataldi, A. A., Bigi, F.
(2002). Negative transcriptional regulation of the mce3 operon in Mycobacterium tuberculosis. Microbiology
148: 2997-3006
[Abstract]
[Full Text]
-
Namwat, W., Kinoshita, H., Nihira, T.
(2002). Identification by Heterologous Expression and Gene Disruption of VisA as L-Lysine 2-Aminotransferase Essential for Virginiamycin S Biosynthesis in Streptomyces virginiae. J. Bacteriol.
184: 4811-4818
[Abstract]
[Full Text]